Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancerPaul A. Cohen, Michael Friedländer, Rachael L. Morton et al.|International Journal of Gynecological Cancer|2021Cited by 12
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsyPaul A. Cohen, C. David Wrede, Yee Leung et al.|Gynecologic Oncology|2020Cited by 9
<u>Ex</u>cisional Treatment&nbsp; <u>C</u>omparison For&nbsp; <u>I</u>n&nbsp; <u>S</u>itu&nbsp; <u>E</u>ndocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone BiopsyPaul A. Cohen, C. David Wrede, Yee Leung et al.|SSRN Electronic Journal|2020Cited by 0